Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04444518 · ClinicalTrials.gov registry record · NA
Increasing Influenza and Tdap Vaccination of Pregnant Women
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 12,760
- Enrollment target
NCT04444518 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 12,760 participants.
The verdict
NCT04444518, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,760 participants
- Enrollment target
Study Summary
Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL VAX-MOM Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,760 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04444518
The ClinicalTrials.gov registry entry for NCT04444518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12,760 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04444518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04444518 about?
NCT04444518 is a clinical study titled "Increasing Influenza and Tdap Vaccination of Pregnant Women". Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women ar...
What is the current status of trial NCT04444518?
This trial is currently completed. It is a NA study. The enrollment target is 12,760 participants. The study started on 2019-07-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04444518?
The interventions under investigation include: Standard of Care (BEHAVIORAL), VAX-MOM Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04444518?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.